您的位置: 首页 > 农业专利 > 详情页

IMPROVED HLA EPITOPE PREDICTION
专利权人:
The Broad Institute, Inc.;Massachusetts Institute of Technology;President and Fellows Harvard College;Dana Farber Cancer Institute, Inc.;The General Hospital Corporation
发明人:
Steven A. Carr,Nir Hacohen,Catherine J. Wu,Jennifer G. Abelin,Siranush Sarkizova,Derin B. Keskin,Karl R. Clauser,Michael S. Rooney
申请号:
US16094786
公开号:
US20190346442A1
申请日:
2017.04.18
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Adaptive immune responses rely on the ability of cytotoxic T cells to identify and eliminate cells displaying disease-specific antigens on human leukocyte antigen (HLA) class I molecules. Investigations into antigen processing and display have immense implications in human health, disease and therapy. To extend understanding of the rules governing antigen processing and presentation, immunopurified peptides from B cells, each expressing a single HLA class I allele, were profiled using accurate mass, high-resolution liquid chromatography-mass spectrometry (LC-MS/MS). A resource dataset containing thousands of peptides bound to 28 distinct class I HLA-A, -B, and -C alleles was generated by implementing a novel allele-specific database search strategy. Applicants discovered new binding motifs, established the role of gene expression in peptide presentation and improved prediction of HLA-peptide binding by using these data to train machine-learning models. These streamlined experimental and analytic workflows enable direct identification and analysis of endogenously processed and presented antigens.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充